Biogen Idec has submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval. The drug, called Plegridy, is intended to treat patients with relapsing forms of multiple sclerosis, a disease of the immune system in which the body attacks the brain and spinal cord.
The new agitator blade is designed for the line of double planetary mixers. The 100-gallon model is equipped with two identical rectangular stirrers with upward rake fingers. Designed to rotate on their own axes while orbiting the vessel on a common axis, these style blades are ideal for batching dry powder blends, wet granulations and similar formulations in the double planetary mixers.
The makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the public about the product's safety. But after years of delays in one of France's biggest recent health scandals, the proceedings could still be pushed back further.
The Cognex Industrial Camera (CIC) series has a new line of GigE Vision® digital industrial cameras designed for easy integration with VisionPro® and CVL® vision software. The first four models of the CIC series are compact, monochrome, area scan cameras.
Startups are coming up with new technologies, such as "digital pills" and social games with rewards, aimed at getting people to take medicine only as directed. A range of startup companies are trying to use technology to come up with more cost-effective ways to get medication used properly.
Shares of AcelRx Pharmaceuticals Inc. hit an all-time high price Tuesday, after the specialty drugmaker said its NanoTab pain treatment system met its main goal in late-stage research, and the company is preparing to submit it to regulators for approval. The Redwood City, Calif., company said...
Shares of Peregrine Pharmaceuticals surged Monday after the company said it would move ahead with a late-stage trial of its lead product, the experimental lung cancer treatment bavituximab. Peregrine said in a release it reached an agreement with the Food and Drug Administration on a phase III study of its drug involving 600 patients.
Shares of XenoPort Inc. sank Monday after the drug developer said a potential treatment for multiple sclerosis patients failed in late-stage clinical testing, and it will stop developing the drug. The Santa Clara, Calif., company said the treatment, labeled arbaclofen placarbil, failed to show a statistically significant improvement for patients taking it compared to a fake drug.
Royalty Pharma has raised its offer to buy Elan on the condition that shareholders reject the Irish drugmaker's push to refocus its business through a string of recently announced deals, including two new deals unveiled Monday. Royalty said Monday it will pay $12.50 in cash for each share of Elan Corp. PLC. That adds up to a total value of about $7.5 billion.
Cattle feeders in the U.S. are coping with reduced herds and high corn costs in part by increasing their use of growth-inducing drugs designed to bulk up animals, get more pounds of beef from each carcass and circumvent the drought's withering effects on the food cycle.
Xellia Pharmaceuticals, a pharmaceutical group focusing on the development, manufacturing and global commercialization of anti-infective therapies, announced today that Novo A/S, the holding company of the Novo Group, has purchased all shares of the group for approximately US$ 700 million from 3i and other current shareholders.
Pfizer has halted a late-stage study of an experimental cancer compound being tested in patients with a certain form of non-Hodgkin's lymphoma, because an interim analysis showed the drug wasn't helping patients live longer. Pfizer said late Monday that it was stopping the study...
The development of new technology to coat is vital to achieving the desired results in the absorption process. Introducing a new concept in tablet coating systems that can be custom designed and optimized for flexibility and a variety of tablet coating requirements.
The premium laboratory balance Cubis even more user-friendly to ensure reliable, error-free results. Sartorius Q-Apps can now be installed on any Cubis balance to guide users quickly and easily in performing any weighing application.
Compared to other conventional heating and drying methods, microwaves provide pharmaceutical processors another option to achieve optimal formulations. The custom-designed, microwave-mixers are capable of maintaining long-term drug stability with stringent granule characteristics.